Centre of Excellence in Personalised Medicine
PerMedCoE is the HPC/Exascale Centre of Excellence for Personalised Medicine in Europe and aims to provide an efficient and sustainable entry point to the HPC/Exascale-upgraded methodology to translate omics information into actionable models of cellular functions of medical relevance. Coordinated by the Barcelona Supercomputing Center (BSC), this CoE has been awarded €5 million in funding from the European Commission and will run from 1 October 2020 to 30 September 2023.
Latest PerMedCoE News
Overview of the goals and objectives of PerMedCoE, the European HPC/Exascale Centre of Excellence on Personalised Medicine
PerMedCoE: HPC-enabled multiscale simulation helps uncover mechanistic insights of the SARS-CoV-2 infection
In this use case, PermedCoE’s main aim is to uncover mechanistic insights that could help in the fight against SARS-CoV-2. Researchers use Boolean models of signalling pathways, agent-based models for populations of cells and the communication among virus, epithelial host cells and immune cells.
This article gives an overview over the various ways in which EU projects are using supercomputing applications to tackle and support the global challenge of containing the corona virus pandemic.